11 In our recently published paper, we demonstrated that intraperitoneal (IP) administration of hPMSC, at the time of reperfusion, produced highly significant protection against injury in our filament induced MCAO model.
← all excerpts
Human placenta mesenchymal stem cell protection in ischemic stroke is angiotensin converting enzyme-2 and masR receptor-dependent.
1
—
—